Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $545 Billion
- Q3 2025
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 9,290,960 shares of APLS stock, worth $189 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
9,290,960
Previous 8,976,962
3.5%
Holding current value
$189 Million
Previous $155 Million
35.31%
% of portfolio
0.04%
Previous 0.03%
Shares
24 transactions
Others Institutions Holding APLS
# of Institutions
329Shares Held
124MCall Options Held
4.15MPut Options Held
769K-
Avoro Capital Advisors LLC New York, NY12.2MShares$248 Million3.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.99MShares$203 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.64MShares$196 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT8MShares$163 Million5.71% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$118 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.23B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...